Cargando…

LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP

BACKGROUND: LOX-like 1 (LOXL1) is a lysyl oxidase, and emerging evidence has revealed its effect on malignant cancer progression. However, its role in colorectal cancer (CRC) and the underlying molecular mechanisms have not yet been elucidated. METHODS: LOXL1 expression in colorectal cancer was dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Lin, Wang, Jing, Wang, Yunliang, Wu, Linpeng, Wu, Chao, Mao, Bo, Maruthi Prasad, E., Wang, Yuhong, Chin, Y. Eugene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488294/ https://www.ncbi.nlm.nih.gov/pubmed/32912229 http://dx.doi.org/10.1186/s12964-020-00639-1

Ejemplares similares

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
por: Tian, Jing, et al.
Publicado: (2019)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
por: Park, Pil-Gu, et al.
Publicado: (2017)

Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)

Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis
por: Zhang, Huan, et al.
Publicado: (2021)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins
por: Eraso, Pilar, et al.
Publicado: (2023)

Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway
por: Cheng, Fang, et al.
Publicado: (2023)

Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma
por: Yang, Jia, et al.
Publicado: (2023)

High-mobility group A1 (HMGA1) gene expressions in various colorectal cancer cell lines and correlation with prognosis
por: E., Maruthi Prasad, et al.
Publicado: (2020)

LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression()
por: Jiao, Ji-Wei, et al.
Publicado: (2022)

Increased serum LOXL2 concentration in pelvic inflammatory disease with pelvic adhesion
por: Xie, Chan, et al.
Publicado: (2022)

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
por: Cui, Jie, et al.
Publicado: (2021)

Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
por: Vázquez-Naharro, Alberto, et al.
Publicado: (2022)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
por: Pan, Beiqing, et al.
Publicado: (2019)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1
por: Wang, Jianlin, et al.
Publicado: (2019)

Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting
por: Radić, Jelena, et al.
Publicado: (2023)

Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese
por: Lee, Kelvin Y.C., et al.
Publicado: (2009)

LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4
por: Ji, Yanzhao, et al.
Publicado: (2022)

Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
por: Zhang, Xi, et al.
Publicado: (2018)

Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population
por: Chen, Ling, et al.
Publicado: (2009)

YAP at the progression of inflammation
por: Chen, Libin, et al.
Publicado: (2023)

Targeting YAP-dependent MDSC infiltration impairs tumor progression
por: Wang, Guocan, et al.
Publicado: (2015)

Pinocembrin Protects Against Dextran Sulfate Sodium-Induced Rats Colitis by Ameliorating Inflammation, Improving Barrier Function and Modulating Gut Microbiota
por: Hu, Lin, et al.
Publicado: (2019)

LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
por: Yuan, Ruiyan, et al.
Publicado: (2021)

Cleavage of LOXL1 by BMP1 and ADAMTS14 Proteases Suggests a Role for Proteolytic Processing in the Regulation of LOXL1 Function
por: Rosell-García, Tamara, et al.
Publicado: (2022)

Unbalanced YAP–SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma
por: Wang, Lianghai, et al.
Publicado: (2018)

YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
por: Li, Wei, et al.
Publicado: (2017)

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
por: Zhang, Caixia, et al.
Publicado: (2021)

Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1
por: Pasutto, Francesca, et al.
Publicado: (2017)

MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1
por: Liu, Xiaomin, et al.
Publicado: (2020)

LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

LAMA2 and LOXL4 are candidate FSGS genes
por: Vijayan, Poornima, et al.
Publicado: (2021)

LOXL2 in Cancer: A Two-Decade Perspective
por: Cano, Amparo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vv7q7dtne3q88b98a7etd5vu8g